Protarga to Begin Pivotal Phase III Study of New Cancer Drug In Patients with Metastatic Melanoma On PR Newswire: Biotech/Healthcare
New tool for melanoma prognosis "HealthandAge.com" On Seniors news
QLT and Novartis Ophthalmics launch phase III program to treat skin cancer "Stock Quote: QLT" On Advice For Investors